NDC Package 76346-073-02 Korlym Tablet Oral - NDC List
What is NDC 76346-073-02? The NDC Packaged Code 76346-073-02 is assigned to a package of 280 tablet in 1 bottle of Korlym, a human prescription drug labeled by Corcept Therapeutics …
NDC Package 76346-073-01 Korlym Tablet Oral - NDC List
The NDC Packaged Code 76346-073-01 is assigned to a package of 28 tablet in 1 bottle of Korlym, a human prescription drug labeled by Corcept Therapeutics Incorporated.
NDC 76346-073 Korlym Tablet Oral - NDC List
The NDC code 76346-073 is assigned by the FDA to the product Korlym which is a human prescription drug product labeled by Corcept Therapeutics Incorporated. The generic name of …
KORLYM (mifepristone) is a cortisol receptor blocker indicated to control hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome who …
Korlym (mifepristone) is a cortisol receptor blocker indicated to control hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome who have type 2 …
Mifepristone Tablets - USA - Teva USA
Save money on your Korlym® Tablets prescription by switching to Teva's FDA-approved generic version, Mifepristone Tablets
76346-0073 Korlym - CanMED: NDC - Surveillance, Epidemiology, …
CanMED: NDC. The Cancer Medications Enquiry Database (CanMED) is a two-part resource for cancer drug treatment related studies. An official website of the United States government
Korlym® - ASD Healthcare
Korlym® NDC #: 76346-0073-01. Generic Name: Mifepristone. Size: 300 mg/28 tabs. Pack/Case: btl
S0190 Mifepristone - CanMED: HCPCS - Surveillance, …
The Cancer Medications Enquiry Database (CanMED) is a two-part resource for cancer drug treatment related studies.
Korlym: Uses, Dosage, Side Effects & Warnings - Drugs.com
2024年1月3日 · Korlym (mifepristone) is used to control high blood sugar levels (hyperglycemia) in adults with endogenous Cushing’s syndrome. Includes Korlym side effects, interactions and …